ABIGAYLE CROSS: Open Payments
NPI 1225790280 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$808 in 30 payments from 10 companies in 2025. Trend: 2023 $42 · 2024 $392 · 2025 $808
Food & beverage: $755Education: $53
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 8 | $234 |
| Regeneron Healthcare Solutions, Inc. | 6 | $211 |
| Inspire Medical Systems, Inc. | 8 | $189 |
| SANOFI-AVENTIS U.S. LLC | 1 | $53 |
| Paratek Pharmaceuticals, Inc. | 2 | $32 |
| Optinose US, Inc. | 1 | $21 |
| Amgen Inc. | 1 | $20 |
| Smith+Nephew, Inc. | 1 | $20 |
| Hikma Pharmaceuticals USA | 1 | $15 |
| Integra LifeSciences Corporation | 1 | $14 |
Products named: DUPIXENT, INSPIRE, XHANCE, TEZSPIRE, HALO, Ryaltris, ACCLARENT AERA.
Industry payments across TX — which companies pay providers there.
